Skip to main content
logo
AstraZeneca Pharma India Limited (BOM:506820)
India flag India · Delayed Price · Currency is INR
8,347.05
+94.80 (1.15%)
At close: Jan 22, 2026

AstraZeneca Pharma India Revenue

AstraZeneca Pharma India had revenue of 5.59B INR in the quarter ending September 30, 2025, with 37.03% growth. This brings the company's revenue in the last twelve months to 20.06B, up 35.14% year-over-year. In the fiscal year ending March 31, 2025, AstraZeneca Pharma India had annual revenue of 17.16B with 32.48% growth.

Revenue (ttm)
20.06B
Revenue Growth
+35.14%
P/S Ratio
10.40
Revenue / Employee
33.44M
Employees
802
Market Cap
208.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202517.16B4.21B32.48%
Mar 31, 202412.96B2.93B29.17%
Mar 31, 202310.03B1.97B24.50%
Mar 31, 20228.06B-79.60M-0.98%
Mar 31, 20218.14B-182.50M-2.19%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jubilant Pharmova76.18B
Abbott India67.14B
Granules India48.42B
J. B. Chemicals & Pharmaceuticals41.93B
GlaxoSmithKline Pharmaceuticals37.09B
Caplin Point Laboratories20.42B
Sanofi India19.33B
Viyash Scientific16.58B
Revenue Rankings

AstraZeneca Pharma India News

More News